Principal Financial Group Inc. Takes $329,000 Position in Harrow, Inc. (NASDAQ:HROW)

Principal Financial Group Inc. acquired a new stake in shares of Harrow, Inc. (NASDAQ:HROW) in the 3rd quarter, HoldingsChannel reports. The institutional investor acquired 7,320 shares of the company’s stock, valued at approximately $329,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in HROW. Virtu Financial LLC bought a new stake in Harrow during the third quarter worth about $271,000. Geode Capital Management LLC raised its holdings in Harrow by 0.6% in the third quarter. Geode Capital Management LLC now owns 722,730 shares of the company’s stock worth $32,500,000 after purchasing an additional 3,960 shares in the last quarter. Barclays PLC increased its stake in shares of Harrow by 301.9% during the third quarter. Barclays PLC now owns 52,593 shares of the company’s stock valued at $2,365,000 after purchasing an additional 39,506 shares in the last quarter. XTX Topco Ltd bought a new position in shares of Harrow during the third quarter valued at $487,000. Finally, Wellington Management Group LLP increased its position in shares of Harrow by 3.6% during the third quarter. Wellington Management Group LLP now owns 103,179 shares of the company’s stock valued at $4,639,000 after acquiring an additional 3,612 shares in the last quarter. 72.76% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on HROW. Lake Street Capital increased their price objective on shares of Harrow from $45.00 to $55.00 and gave the company a “buy” rating in a research report on Friday, October 4th. Craig Hallum increased their price objective on shares of Harrow from $45.00 to $65.00 and gave the company a “buy” rating in a report on Friday, October 4th. Finally, B. Riley lowered their target price on Harrow from $73.00 to $69.00 and set a “buy” rating for the company in a research report on Wednesday, December 4th.

Harrow Stock Down 1.0 %

Shares of NASDAQ:HROW opened at $35.96 on Tuesday. The business has a 50 day simple moving average of $40.31 and a two-hundred day simple moving average of $38.06. Harrow, Inc. has a 1 year low of $9.13 and a 1 year high of $59.23. The company has a debt-to-equity ratio of 3.23, a current ratio of 1.55 and a quick ratio of 1.44. The firm has a market capitalization of $1.28 billion, a PE ratio of -38.26 and a beta of 0.72.

Harrow Company Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.